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We performed a pathologic study with further using an immunohistochemical technique (usinganti-p63 and anti-CK5)on tissues
obtained by open lung biopsy from 18 patients with previous exposure to sulphur mustard (SM) as case group and 8 unexposed
patients (control group). The most frequent pathologic diagnosis was constrictive bronchiolitis (44.4%), followed by respiratory
(22.2%)andchroniccellularbronchiolitis(16.7%)inthecasegroup,andhypersensitivitybronchiolitis(50%)inthecontrolgroup.
The pathologic diagnoses were signiﬁcantly diﬀerent in the case and control groups (P = 0.042). In slides stained by anti-p63 and
anti-CK5, the percent of stained cells and the mean number of epithelial cells were lower in the case group in comparison to
the control group. This diﬀerence was signiﬁcant for the mean number of cells stained by anti-CK5 (P = 0.042). Furthermore,
there was a signiﬁcant correlation between pathologic diagnosis and total number of cells and mean number of cells stained with
anti-p63 and anti-CK5 (P value = 0.002, <0.001, 0.044). These results suggest that constrictive bronchiolitis may be the major
pathologic consequence of exposure to SM. Moreover, decrease of p63 in respiratory tissues aﬀected by SM may suggest the lack
of regenerative capacity in these patients.
1.Introduction
Previous studies have reported that exposure to sulphur
mustard (SM) can lead to the development of airway hyper-
reactivity [1], chronic bronchitis, bronchiectasis, and lung
ﬁbrosis [2, 3], in chronic phase. However, recent studies
have shown strong evidence that constrictive bronchiolitis
may also be a main late complication in exposure to SM
[2,4–7].Somestudieshavetriedtoillustratethepathological
features in persons exposed to SM. In a study using broncho-
alveolar lavage (BAL), ﬁbrosis, ﬁbroblast proliferation, and
increased collagen synthesis were observed in the patient
respiratory parenchyma [4], consistent with the diagnosis of
constrictive bronchiolitis [8, 9]. In another study obtaining
tissue by BAL and transbronchial lung biopsy, evidence of
organizing pneumonia or constrictive bronchiolitis with or-
ganizing pneumonia was observed [10]. Considering the val-
ue of pathology in the diagnosis however, immunostaining
methods can conﬁrm or further add to the data obtained
from pathology, using antibodies against markers expressed
in bronchial structures. Among the common used markers
are cytokeratin (CK8) and surfactant (alveolar markers),
CK5 and P63 (bronchial epithelial markers), CD34, CD31,
and podoplanin (endothelial markers), and α-SMA (smooth
muscle α-actin; ﬁbroblast and myoﬁbroblast marker) [11–
13]. In our previous studies, we had shown that in SM-
exposed patients, the pathology is centered in bronchioles.
CK5andP63arebronchialepithelialmarkerswhichcanhelp2 Pathology Research International
to detect remnants of bronchioles (vanished bronchioles,
whichareseverelyinjuredanddistortedbronchioles)incases
in which conventional pathologic staining had failed to help.
Immunohistochemistry may also provide additional infor-
mation about the pathogenesis of SM.
As no large comprehensive study has yet reported im-
munohistochemical features of people exposed to SM, we
performed a collaborative international study in which we
used antibodies against CK5 and P63 in tissues obtained by
open lung biopsy from patients with previous exposure to
SM.
2. Methods
2.1. Patient Population and Data Acquisition. Data were ob-
tained from the medical records available at a major uni-
versity hospital which provides tertiary medical care for pa-
tients exposed to chemical warfare agents during the Iran-
Iraq war. The inclusion criteria were as follows: (1) patients
who had experienced some level of exposure to SM and (2)
patients who had undergone a surgical (open or thoraco-
scopic) lung biopsy, pulmonary function tests (PFTs), and
chest high-resolution-computed tomography scan (HRCT).
Patients were excluded if they had a history of signiﬁcant
occupational or other environmental exposures or a connec-
tive tissue disease. Smoking was not a reason for exclusion.
Only two cases and none of controls were smokers, however.
18 patients ﬁnally met our inclusion criteria. Eight patients
with the second inclusion criteria (as mentioned above) who
had no history of sulphur mustard gas exposure were in-
cluded in the study to serve as controls. These patients (in
fact controls), were chosen among unexposed patients who
presented with respiratory complaints and had undergone
the above-mentioned evaluations. Cases and controls were
selected in a consecutive manner.
All patients had signed an informed consent before par-
ticipating in the study (including their consent to undergo a
lungbiopsyprocedure)andallprocedureswereconductedin
accordancewiththeprinciplesofdeclarationofHelsinki,and
the project design was approved by appropriate institutional
ethics committee.
2.2. Surgical Procedure. Surgical procedures were performed
under general anesthesia. If possible, biopsies were obtained
from two diﬀerent lobes of the lung at the interface between
apparently normal and pathologic tissues. All specimens
were ﬁxed in formalin and embedded in paraﬃn according
to standard laboratory procedures and sent to pathology lab
immediately. Specimens were stained by hematoxylin-eosin,
Masson’s trichrome, and elastic tissue stains for pathologic
review.
2.3. Immunohistochemical Procedure. Immunostaining was
performed on formalin-ﬁxed, paraﬃn-embedded sections
using DAKO immunostaining methods (DAKO EnVision
System, DAKO, A/S, Glostrup, Denmark), and all procedures
were performed according to the manufacturer’s protocols.
Four-μm-thick sections were deparaﬃnized, rehydrated, and
t r e a t e dw i t h3 %h y d r o g e np e r o x i d ef o r1 0m i n u t e st ob l o c k
endogenous peroxidase activity. For antigen retrieval, the
sections were then heated in a microwave oven (750W for
15min with 0.01M citric acid, pH 6.0). The sections were
washed in phosphate-buﬀered saline (PBS) and incubated
with the appropriate primary antibody overnight at room
temperature. The antibodies used were as follows: anti-
human cytokeratin 5/6 antibody (monoclonal mouse IgG1
antiserum, DAKO) for CK5; anti-human P63 antibody
(monoclonal mouse antiserum, DAKO) for P63. For detec-
tion of primary antibodies, specimens were washed in PBS,
followed by incubation with avidin-biotin-peroxidase com-
plex according to the manufacturer’s instructions. Hema-
toxylin was used as the nuclear counterstain. To evaluate
the speciﬁcity of the antibody, known positive and negative
tissueswereusedascontrols.Inordertogradetheimmunos-
taining,astandardpowerﬁeldwasselectedinallsectionsand
then each section was divided into equal number of squares.
The total number of bronchial epithelial cells, number of
cells stained for p63 or CK5, and the percent of stained cells
in each square were then calculated and used for further
analysis. For anti-cytokeratin 5, diﬀuse, focal cytoplasmic, or
membrane staining was scored as positive reactivity, and p63
expression was considered positive only if distinct nuclear
staining was present.
2.4. Data Analysis and Review. All sections were initially
studied in a blinded fashion without knowledge of clinical
features by 6 pathologists from Iran (Research Center of
Chemical Injuries, Baqiyatallah Medical Sciences University,
Tehran and Department of pathology, Shaheed Beheshti
University of Medical Sciences, Tehran), Italy (Department
of Pathology, University of Verona), and USA (Department
of Laboratory Medicine and Pathology, Mayo Clinic, Ari-
zona). Afterwards, all cases were reviewed regarding com-
plete clinical history, radiological ﬁndings, and collected
immunohistochemical results. A ﬁnal diagnosis was then
determined for each patient. All data were analyzed with the
commerciallyavailablesoftwarepackageSPSS(version13.0).
3. Results
Between February 2004 and May 2005, 18 SM-exposed
patients (all male, case group) and 8 unexposed patients (7
females and 1 male, control group) who met our inclusion
criteria participated in this study. The mean ages of the cases
and controls were 43.9 ± 9.6 (range 33–65) and 42.6 ± 10.8
(range 29–66), respectively, which was not signiﬁcantly
diﬀerent (independent t-test, P = 0.85). The mean interval
between exposure and involvement in the study for cases
was 19.4 years (range 17–23). Two patients were smokers. All
patients (100%) presented dyspnea and cough as their main
complaint, while sputum production (60%), hemoptysis
(46.7%), and chest pain (40%) were the other frequent
complaints in patients. Obstructive lung pattern was seen
in 11 (73.3%), mixed or restrictive pattern in 2 patients
(13.3%), and 2 patients (13.3%) had normal pulmonary
function test results.Pathology Research International 3
Table 1: Pathologic diagnosis of cases and controls.
Case group Control group
Diagnosis Number of cases (%) Diagnosis Number of cases (%)
Constrictive bronchiolitis 8 (44.44) Hypersensitivity bronchiolitis 4 (50)
Respiratory bronchiolitis 4 (22.22) Bronchiolitis obliterans organizing pneumonia (BOOP) 1 (12.5)
Chronic cellular bronchiolitis 3 (16.67) Chronic cellular bronchiolitis 1 (12.5)
Hypersensitivity bronchiolitis 1 (5.56) Constrictive bronchiolitis 1 (12.5)
Nonspeciﬁc bronchiolitis 1 (5.56) Neuroendocrine bronchiolitis 1 (12.5)
Indeﬁnite 1 (5.56)
Table 2:IHCﬁndingsincontrolandcasegroups.Thenumberofcellsrepresentsthenumberofcells(whetherstainedornot)ineachsquare,
as described in the methods. Each square in all slides was approximately equal to 0.7980mm2. The number of bronchioles is represented in
a slide observed in a low-power ﬁeld view.
∗P < 0.05 compared to the relevant control group.
P63 staining CK5 staining Number of bronchioles
Mean number of
cells (± SD )
P e r c e n to fs t a i n e d
cells (± SD )
Mean number of
cells (± SD )
P e r c e n to fs t a i n e d
cells (± SD ) Total Intact Injured
Control 13.89 ± 3.33 50.16 ± 3.15 16.44 ± 2.44 50.94 ± 30.36 3.0 2.67 0.33
Case 12.11 ± 5.21 42.11 ± 19.32 10.99 ± 3.99∗ 37.20 ± 22.50 2.44 1.83 0.61
P value 0.43 0.16 0.042 0.34 0.47 0.25 0.26
3.1. Pathological and Immunohistochemical Findings. Patho-
logic studies revealed that all cases had evidence of pathology
centered on the small airways. As shown in Table 1, the most
frequent diagnosis in the case group was constrictive bron-
chiolitis (8 patients; 44.4%) which was deﬁned by partial
luminal narrowing by the presence of plaque-like increases
in circumferential or partial submucosal collagen. The next
most common diagnoses were respiratory and chronic cellu-
larbronchiolitis, whichconsistedof4(22.2%)and3(16.7%)
patients, respectively. Other less frequent diagnoses were
hypersensitivity bronchiolitis and nonspeciﬁc bronchiolitis.
One specimen showed inadequate and equivocal ﬁndings
which made a deﬁnite pathologic diagnosis impossible to
make. The pathological diagnoses in the control group were
hypersensitivity bronchiolitis (50%), bronchiolitis obliterans
organizing pneumonia (BOOP) (12.5%), chronic cellular
bronchiolitis (12.5%), constrictive bronchiolitis (12.5%),
and neuroendocrine bronchiolitis (12.5%). Chi-square anal-
ysis showed that the pathologic diagnoses were signiﬁcantly
diﬀerent in the case and control groups (P = 0.042) as there
was a higher rate of constrictive bronchiolitis in the case
group, in comparison to the control group.
Immunohistochemical staining for CK5 and p63 data is
shown in Tables 2 and 3. As shown in Table 2, the percent of
stained cells and the mean number of cells in slides stained
by anti-p63 and anti-CK5 were lower, in the case group in
comparison to the control group. Furthermore, independent
t-test analysis showed that this diﬀerence was signiﬁcant
for the mean number of cells stained by anti-CK5 (P =
0.042). Also, the mean number of bronchioles and the mean
numberofintactbronchioleswerelowerandthemeannum-
ber of injured bronchioles was higher in the case group in
comparison to the control group; however, the diﬀerences
were not statistically signiﬁcant (independent t-test, P
values = 0.47, 0.25, and 0.26, resp.). We further analyzed
the correlation between each pathologic diagnosis and the
Immunohistochemistry measures. One-way analysis of vari-
ance (ANOVA) showed that there was a signiﬁcant eﬀect of
pathologic diagnosis on mean number of cells stained with
anti-p63, mean number of cells stained with anti-CK5,
and total number of cells (One-way ANOVA, P value =
<0.001, 0.044, and 0.002). The eﬀect of pathologic diag-
nosis on percent of cells stained by anti-p63 or anti-CK5,
mean number of vanished, intact, injured and total bron-
chioles was not signiﬁcant (One-way ANOVA, P values =
0.26, 0.40, 0.24, 0.95, 0.59, and 0.97, resp.). The mean
number of cells and the percent of cells stained by anti-p63
and anti-CK5 are shown in Table 3.
4. Discussion
SMisreportedtocauseongoinginjurythatmaynotmanifest
itself for many years; among them, the most common late
complications of exposure are respiratory complications.
Previous studies have mostly reported chronic bronchitis,
asthmatoid bronchitis, lung ﬁbrosis, bronchiectasis, and
bronchial stenosis as the main late complications of exposure
[3]. However, none of these studies have assessed the respira-
tory eﬀects of SM exposure pathologically, and most of these
studies arebased on clinical, spirometric, and/or radiological
ﬁndings, which have their own pitfalls. Therefore, some re-
cent more comprehensive and multicenter studies, adding
pathology ﬁndings to their current radiological data, have
tried to further increase the reliability of their ﬁndings. This
way, a number of studies have shown some evidence that
constrictive bronchiolitis may be the main late complication
in patients exposed to SM [2, 4, 7, 10]. In the current study,
this was further conﬁrmed, as we observed more patients4 Pathology Research International
(a) (b)
(c) (d)
(e)
Figure 1: Pathologic evidence of constrictive bronchiolitis in a mustard-gas-exposed patients, stained with H & E (a), anti-CK5 (b), and
anti P63 (c), respectively. (d) and (e) show anti-CK5 and anti-P63 staining in an unexposed patient (control) diagnosed as hypersensitivity
pneumonitis.
pathologically diagnosed as constrictive bronchiolitis in the
group previously exposed to sulphur mustard (Figure 1).
Constrictive bronchiolitis is a relatively rare disease
which occurs mostly in patients with a history of previous
childhood infections, toxic fume inhalation (such as diacetyl
[1]a n dS M[ 3, 7, 14, 15], graft-versus-host disease and
chronic rejection following bone marrow, lung or heart-lung
transplantation [16, 17], and other clinical settings. Patho-
logically, it is characterized by a distinctive pattern of chron-
ic peribronchiolar inﬂammation, inﬁltration, and ﬁbrosis
which surrounds rather than ﬁlls the lumen, ultimately re-
sulting in airway obstacle, cicatrisation of the bronchiolar lu-Pathology Research International 5
(a) (b)
Figure 2: Evidence of vanished bronchioles in 2 mustard-gas-exposed patients. Scant staining, with anti-P63 (arrows), distinguishes the
remnants of injured bronchioles from nonbronchiolar tissue.
Table 3: The IHC data, regarding each pathologic diagnosis. The number of cells represents the number of cells (whether stained or not)
in each square, as described in the methods. Each square in all slides was approximately equal to 0.7980mm2. The number of bronchioles is
represented in a slide observed in a low-power ﬁeld view.
P63 staining CK5 staining Number of bronchioles
(intact + injured)
Percent of
patients with
vanished
bronchioles
Mean number of
cells (± SD )
P e r c e n to fs t a i n e d
cells (± SD )
Mean number of
cells (± SD )
P e r c e n to fs t a i n e d
cells (± SD )
Constrictive
bronchiolitis 9.62 ± 3.19 39.12 ± 15.88 10.27 ± 2.65 26.40 ± 13.80 2.63 (2.00 + 0.63) 75.0
Chronic cellular
bronchiolitis 18.24 ± 2.00 47.38 ± 24.00 13.99 ± 2.56 57.72 ± 7.30 2.25 (1.75 + 0.50) 33.3
Hypersensitivity
pneumonitis 13.08 ± 3.26 47.22 ± 6.15 12.08 ± 3.25 55.74 ± 31.30 2.80 (2.60 + 0.20) 25.0
Respiratory
bronchiolitis 13.71 ± 3.35 50.17 ± 38.24 11.33 ± 6.85 39.79 ± 33.67 2.25 (1.75 + 0.50) 0
Neuroendocrine
bronchiolitis 18.57 26.67 19.14 15.85 3.00 (2.00 + 1.00) 100.0
Nonspeciﬁc
bronchiolitis 12.15 40.73 10.29 39.92 2.00 (1.00 + 1.00) 100.0
men, and airway loss [4, 18]. Some other types of bronchi-
olitis are in the diﬀerential diagnosis of constrictive bronchi-
olitis, including respiratory bronchiolitis and cellular bron-
chiolitis. Respiratory bronchiolitis is deﬁned by the pres-
ence of pigmented macrophages within the lumen of dis-
tal airways, not associated with signiﬁcant inﬂammation,
ﬁbroblast activity, or collagen deposition. In cellular bron-
chiolitis, the bronchioles show an increased number of
acute (neutrophils) or chronic (lymphocytes, plasma cells,
macrophages, or tan-brown histiocytes) inﬂammatory cells
(luminal, mural, or both), accompanied by necrosis of ep-
ithelial and inﬂammatory cells, submucosal edema or ne-
crosis, neutrophil microabscesses, and germinal center hy-
perplasia (follicular bronchiolitis). However, advanced cases
of constrictive bronchiolitis may be especially diﬃcult to
diﬀerentiate because of lack of active inﬂammation and
disappearance of bronchioles (or vanished bronchioles). In
such cases, other staining methods such as elastic and im-
munostaining may be useful in identiﬁcation of aﬀected
structures, by deﬁning speciﬁc markers [18]. Regarding this,
we observed evidence of vanished bronchioles in 4 patients,
which helped us make a deﬁnite pathologic diagnosis
(Figure 2).
A number of immunohistochemical markers have been
suggested as useful markers for epithelial cells. Among these
are cytokeratin (CK5) and p63. CK5, an intermediate mo-
lecular weight keratin, is normally present in basal cells of
complex normal epithelia, such as respiratory, squamous,
myoepithelial, and certain ductal epithelia [13, 19]. CK5
serves as the cytoplasmic marker of bronchial basal epithelial
cells. P63 is a p53 homologue which, in normal tissues,
is present in the basal and suprabasal cell population of
stratiﬁed epithelia such as bronchi and lost in more super-
ﬁcial, terminally diﬀerentiated cell layers [11, 20]. Our6 Pathology Research International
immunohistochemistry results further added some evidence
about SM-mediated injury. Exposure to sulphur mustard
signiﬁcantly decreases the total number of epithelial cells.
It also decreases the number of cells stained for CK5 and
p63 markers, and total and intact bronchioles. However, the
latter decreases were not signiﬁcant, may be because of our
limited number of patients and also because our control
group consisted of unexposed patients and not normal peo-
ple. It is suggested that SM undergoes intramolecular cy-
clization to form intermediates, which, in turn, react with
and alkylate cell constituents, mainly DNA, and also RNA,
proteins, and lipid membranes [21, 22]. These reactions
may result in physiological, metabolic, and genetic failure of
cellular functions. Moreover, we showed that the pathologic
diagnosis signiﬁcantly correlated with these measures. In pa-
tients who were diagnosed as constrictive bronchiolitis, the
number of epithelial cells and cells stained for CK5 and p63
were lower, in comparison to the other diagnoses. P63 has
been shown to play a critical role in development of stratiﬁed
epithelia by maintaining basal cell regenerative capacity [23,
24]. Some isoforms of the p63 gene counteract the apoptotic
and cell cycle inhibitory functions of p53 after DNA damage,
and this property is likely to be central in the cell renewal
strategy of stratiﬁed epithelial tissues [25].
In summary, our results suggest that constrictive bron-
chiolitis may be the major pathologic consequence of ex-
posure to SM. Moreover, decrease of p63 in respiratory tis-
sues aﬀected by SM may suggest the lack of regenerative
capacity in these patients. Further studies are needed to elu-
cidate the detailed mechanisms of SM action.
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